Alzheimers Channel
Topics & Medications
Quicklinks
Related Channels

Razadyne Dosage

The recommended starting Razadyne dosage (for the short-acting form of the drug) is 4 mg twice daily. After four weeks, your healthcare provider may increase your dose to 8 mg twice a day. For long-acting Razadyne, dosing usually starts at 8 mg once daily. This dosage can also be increased after four weeks (and up to a maximum of 24 mg daily).

Razadyne Dosage: An Introduction

The dose of Razadyne® (galantamine hydrobromide) that your healthcare provider recommends will vary depending on a number of factors, including:
 
  • How you respond to Razadyne
  • The type of Razadyne you take (short-acting Razadyne or long-acting Razadyne ER)
  • Other medications you may take
  • Other medical conditions you may have.
     
As is always the case, do not adjust your Razadyne dose unless your healthcare provider specifically instructs you to do so.
 

Razadyne ER Dosing

The starting Razadyne ER dose for Alzheimer's treatment is 8 mg once daily. After four weeks, your healthcare provider may increase the dose to 16 mg once daily. If necessary, your healthcare provider may further increase your dose, up to a maximum of 24 mg once daily after an additional four weeks. Razadyne ER capsules should be taken with food, preferably in the morning.
 
People with liver or kidney disease may need a lower Razadyne ER dosage.
 

Short-Acting Razadyne Dosing

Regular Razadyne tablets and oral solution (liquid) are taken twice daily with food. The starting recommended dose is 4 mg twice daily. After four weeks, your healthcare provider may increase your dose to 8 mg twice daily. If necessary, he or she may further increase your dose to 12 mg twice daily after an additional four weeks. Some people may benefit from an even higher dose (16 mg twice daily), and your healthcare provider may recommend this high dose if you tolerate Razadyne well.
 
People with liver or kidney disease may need a lower Razadyne dosage.
 
5 Tips to Reduce Your Risk of Alzheimer's

Razadyne Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.